Anda di halaman 1dari 4

Bab 1

1. Rasjidi, Imam. 2010. 100 Questions And Answer Kanker Pada Wanita. PT Elex Media
Komputindo: Jakarta.
2. Yuliana Made S. 2013. Evaluasi Proram Vaksinasi Kanker Serviks di Kabupaten
Bandung Tahun 2012. (eds) 2013. Jurnal Community Health. Hal 195.
3. Rasjidi Imam, Sulistiyanto H. 2007. Vaksin Human PapollomaVirus dan Eradikasi
Kanker Mulut Rahim. Sagung Seto. Jakarta; 2007.
4. ICO (Information Centre on HPV and Cancer), 2014. Human Papilloma Virus and
Related

Disease

Report

for

Indonesia

[Accessed

28

Maret

2016]

http://www.hpvcentre.net/statistics/reports/IDN.pdf.
5. Dinas Kesehatan Jawa Timur, 2013. Laporan Surveilans Terpadu Penyakit: Penyakit
Tidak Menular. Laporan. Surabaya: Dinas Kesehatan Provinsi Jawa Timur.
6. Almatin, Isma. 2011. Dahsyatnya Hypnosis Learning. Jogjakarta. Pustaka Widyatama.
7. Sari Adelia Perwita, Syahrul Fariani. 2014 Faktor Yang Berhubungan Dengan Tindakan
Vaksinasi HPV Pada Wanita Usia Dewasa. Jurnal Berkala Epidemiologi, Vol. 2, No. 3 hal
321330
8. Diananda, R., 2008, Mengenal Seluk Beluk Kanker, Cetakan II, Katahati, Yogyakarta.
9. Andrijono. Vaksinasi HPV Merupakan Pencegahan Primer Kanker Serviks. Majalah
Kedokteran Indonesia. 2007;57:5.
10. Suwiyoga, K. Vaksin Human Papillomavirus Sebagai Upaya Pencegahan Primer Kanker
Serviks. Denpasar. 2010;2-17.
11. Curado, M.P., Edwards, B., Shin, H.R., Storm, H., Ferlay, J., Heanue, M., 2007, Cancer
Incidence in Five Continents, IARC Scientific Publications, IX, No. 160, IARC Press,
Lyon.
12. National Cancer Institute, 2006, Cancer Epidemiology in Older Adolescents and Young
Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000,
http://seer.cancer.gov/publications/aya/aya_mono_complete.pdf, cit. Juntasopeepun, P.,
Suwan, N., Phianmongkhol, Y., Srisomboon, J., 2012, Factors Influencing Acceptance of
Human Papillomavirus Vaccinez among Young Female College Students in Thailand,
International Journal of Gynecology and Obstetrics 118, 247250.

Bab 2
1. Savitri Astrid. 2015. Kupas Tuntas Kanker Payudara Leher Rahim dan Rahim. Jakarta.
Penerbit Pusaka Baru Press, hal 96.

2. Rasjidi Imam. 2007. Panduan Penatalaksanaa Kanker Ginekologi. Jakarta. Penerbit Buku
Kedokteran EGC, hal 6.
3. Rasjidi Imam. 2008. Manual Prakanker Serviks Edisi Pertama. Jakarta. Penerbit CV
Sagung Seto, hal 16-9.
4. Urman CO, AB Gottlieb. 2008. New viral vaccines for dermato-logic disease. J Am Acad
Dermatol; 58: 361-70.
5. Wang KL. 2007. Human papillo-mavirus and vaccination in cer-vical cancer. Taiwan J
Obstet Gynecol; 46: 352-62.
6. Gnanamony M, A Peedicayil, P Abraham. 2007. An overview of human papillomaviruses
and cur-rent vaccine strategies. Indian J Med Microbiol; 25: 10-7.
7. Roden R, TC Wu. 2003. Preven-tative and therapeutic vaccines for cervical cancer.
Expert Rev Vaccines; 2: 495-516.
8. Rouzier R, C Uzan, P Collinet. 2007. HPV vaccination: Prin-ciples, results and future
per-spectives. J Gynecol Obstet Biol Reprod; 36: 13-8.
9. Chesson HW, DU Ekwueme, M Saraiya, LE Markowitz. 2008. Cost-effectiveness of
human papillomavirus vaccination in the United States. Emerg Infect Dis; 14: 244-51.
10. Dalimartha, Setiawan. 2004. Deteksi Dini Kanker & Simplisia Antikanker. Jakarta:
Penebar Swadaya Jakarta.
11. Frazer IH, DR Lowy, JT Schiller. 2007. Prevention of cancer through immunization:
Pros-pects and challenges for the 21st century. European Journal of Im-munology;
37(Suppl 1): S148S155.
12. Lollini PL, F Cavallo, P Nanni, G Forni. 2006. Vaccines for tumor prevention. Nature
Reviews Can-cer; 6 (3):204216.
13. Sharma R, CL Sharma. 2007. Quadrivalent human papillo-mavirus recombinant vaccine:
The first vaccine for cervical can-cers. J Cancer Res Ther; 3: 92-5.
14. Hildesheim A, R Herrero, S Wa-cholder, AC Rodriguez, D Solo-mon, MC Bratti, et al.
2007. Ef-fect of human papillomavirus 16/ 18 L1 viruslike particle vaccine among young
women with pre-existing infection: A randomized trial. JAMA; 298: 743-53.
15. Andrijono. 2007. Kanker Serviks. Divisi Onkologi Dep. Obstetri-Ginekologi FKUI
16. Markowitz LE, EF Dunne, M Sa-raiya, HW Lawson, H Chesson, ER Unger, et al. 2007.
Quadri-valent human papillomavirus vaccine. MMWR Recomm Rep; 56: 1-24.
17. Villa LL, RL Costa, CA Petta, RP Andrade, J Paavonen, OE Iver-sen, et al. 2006. High
sustained efficacy of a prophylactic qua-drivalent human papillomavirus types 6/11/16/18
L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer; 95:1459-66.

18. Block SL, T Nolan, C Sattler, E Barr, KE Giacoletti, CD Mar-chant, et al. 2006.
Comparison of the immunogenicity and reac-togenicity of a prophylactic quadrivalent
human papillo-mavirus (types 6, 11, 16, and 18)
19. Paavonen J, D Jenkins, FX Bosch, P Naud, J Salmern, CM Whee-ler, et al. 2007.
Efficacy of a pro-phylactic adjuvanted bivalent L1 virus-like-particle vaccine against
infection with human papillomavirus types 16 and 18 in young women: An interim
analysis of a phase III double-blind randomized controlled trial. Lancet; 369: 2161-70.
20. Harper DM, EL Franco, CM Wheeler, AB Moscicki, B Roma-nowski, CM RoteliMartins, et al. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle
vaccine against human papillomavirus types 16 and 18: Follow-up from a randomized
control trial. Lancet; 367: 1247-55.
21. Kusrini. 2006. Sistem Pakar Teori dan Aplikasi. Yogyakarta. Penerbit CV ANDI
OFFSET, hal 23.
22. Notoatmodjo, Sukidjo., 2003, Pendidikan dan Perilaku Kesehatan, Rineka Cipta, Jakarta.
23. Maramis, W. F., 2006. Sikap dalam Pelayanan Kesehatan. Dalam : Maeamis, W. F., ed
Ilmu Perilaku dalam Pelayanan Kesehatan. Surabaya: Airlangga Universitas Press, 253272.
24. Notoatmodjo, S. 2007. Promosi Kesehatan dan Ilmu Perilaku. Jakarta : Rineka Cipta.
25. Noor, Nur Nasry, 2008. Epidemiologi. Jakarta: Rineka Cipta
26. Rachmani Berlian. 2012. Sikap Remaja Perempuan Terhadap Pencegahan Kanker Serviks
Melalui Vaksinasi HPV di Kota Semarang. Media Kesehatan Masyarakat Indonesia. Vol.
11. No. 1. Hal 36-40
27. Maulana, Heri D.J, 2009. Promosi Kesehatan. Jakarta: EGC
28. Jones, Melissa & Cook, Robert MD, 2010. Intent to Receive an HPV Vaccine Among
University Men and Women and Implications for Vaccine Administration. Journal Of
American College Health, Vol. 57, Nomor 1.
29. Rosenthal, SL., Weiss, TW., Zimet, GD., Ma, L., Good., MB., Vichnin, M.D., 2011.
Predictors Of HPV Vaccine Uptake Among Women Aged 1926: Importance Of A
Physicians Recommendation. Vaccine, Vol 29: 890-895.

30. Martini, Ni Ketut, 2013. Hubungan Karakteristik, Pengetahuan Dan Sikap Wanita
Pasangan Usia Subur Dengan Tindakan Pemeriksaan Pap Smear Di Puskesmas Sukawati
II. Tesis. Denpasar: Universitas Udayana
31. Sari Adelia Perwita, Syahrul Fariani. 2014 Faktor Yang Berhubungan Dengan Tindakan
Vaksinasi HPV Pada Wanita Usia Dewasa. Jurnal Berkala Epidemiologibe, Vol. 2, No. 3
hal 321330
32. Liddon, Nicole C., Hood., Julia E., Leichliter, Jami S., 2012. Intent To Receive HPV
Vaccine And Reasons For Not Vaccinating Among Unvaccinated Adolescent And Young
Women: Findings From The 20062008 National Survey Of Family Growth. Vaccine,
30:2676 2682.
33. Ismiyati, 2000, Penggunaan Obat Secara Bebas oleh Masyarakat di Beberapa Daerah
Kotamadya Yogyakarta dan Kabupaten Sleman, Skripsi, 39-43, Fakultas Farmasi
Universitas Gadjah Mada, Yogyakarta
34. Moreira, Jr.E.D., Oliveira, B.G., Ferraz, F.M., Costa, S., Costa Filho, J.O., Karic, G.,
2006, Knowledge and Attitudes about Human Papillomavirus, Pap Smears, and Cervical
Cancer among Young Women in Brazil: Implications for Health Education and
Prevention, Int J Gynecol Cancer, 16, 599-603.
35. Medeiros, R., Ramada, D., 2011, Knowledge Differences Between Male and Female
University Students about Human Papillomavirus (HPV) and Cervical Cancer:
Implications for Health Strategies and Vaccination, Vaccine, 29, 153160.